Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins

Two packing polymorphs of drug–drug co-crystals between VD₂ and VD₃ exhibit dramatically different properties. Form A presents superior physicochemical properties compared with VD₂ or VD₃ themselves.